SKYCLARYS Trademark

Trademark Overview

On Tuesday, September 3, 2019, a trademark application was filed for SKYCLARYS with the United States Patent and Trademark Office. The USPTO has given the SKYCLARYS trademark a serial number of 88601903. The federal status of this trademark filing is REGISTERED as of Tuesday, May 2, 2023. This trademark is owned by Reata Pharmaceuticals, Inc.. The SKYCLARYS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, and dermatological diseases and disorders, and epilepsy
skyclarys

General Information

Serial Number88601903
Word MarkSKYCLARYS
Filing DateTuesday, September 3, 2019
Status700 - REGISTERED
Status DateTuesday, May 2, 2023
Registration Number7043289
Registration DateTuesday, May 2, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2020

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, and dermatological diseases and disorders, and epilepsy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 13, 2019
Primary Code005
First Use Anywhere DateWednesday, March 1, 2023
First Use In Commerce DateWednesday, March 1, 2023

Trademark Owner History

Party NameBIOGEN MA INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameReata Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrving, TX 75063
Party NameReata Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrving, TX 75063
Party NameReata Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrving, TX 75063

Trademark Events

Event DateEvent Description
Thursday, December 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 6, 2019NEW APPLICATION ENTERED
Friday, September 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 5, 2019ASSIGNED TO EXAMINER
Wednesday, December 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2020PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 13, 2020SOU TEAS EXTENSION RECEIVED
Thursday, August 13, 2020SOU EXTENSION 1 FILED
Thursday, August 13, 2020SOU EXTENSION 1 GRANTED
Saturday, August 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 2, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 2, 2021SOU EXTENSION 2 FILED
Tuesday, March 2, 2021SOU EXTENSION 2 GRANTED
Thursday, March 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 24, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 24, 2021SOU EXTENSION 3 FILED
Tuesday, August 24, 2021SOU EXTENSION 3 GRANTED
Thursday, August 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 2, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 2, 2022SOU EXTENSION 4 FILED
Wednesday, July 27, 2022SOU EXTENSION 5 FILED
Wednesday, March 2, 2022SOU EXTENSION 4 GRANTED
Friday, March 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 27, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 8, 2022SOU EXTENSION 5 GRANTED
Tuesday, August 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 1, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, March 1, 2023USE AMENDMENT FILED
Friday, March 3, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 28, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 29, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 3, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, May 24, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 2, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 2, 2023REGISTERED-PRINCIPAL REGISTER

Related Keywords

skyclarys dermatological ophthalmological diseases disorders epilepsy mitochondrial psychiatric treatment preparations neurological